Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

April 30, 2016

Conditions
Ulcerative Colitis
Interventions
DRUG

SAR339658

"Pharmaceutical form:solution for infusion~Route of administration: intravenous"

OTHER

Placebo

"Pharmaceutical form: solution for infusion~Route of administration: intravenous"

Trial Locations (41)

6020

Investigational Site Number 040003, Innsbruck

11021

Investigational Site Number 840051, Great Neck

14163

Investigational Site Number 276001, Berlin

14642

Investigational Site Number 840071, Rochester

19460

Investigational Site Number 840045, Phoenixville

20246

Investigational Site Number 276007, Hamburg

22908

Investigational Site Number 840068, Charlottesville

31405

Investigational Site Number 840053, Savannah

32789

Investigational Site Number 840048, Winter Park

33025

Investigational Site Number 840008, Miramar

33136

Investigational Site Number 840003, Miami

38043

Investigational Site Number 250003, Grenoble

39564

Investigational Site Number 840060, Ocean Springs

45219

Investigational Site Number 840046, Cincinnati

48098

Investigational Site Number 840070, Rochester Hills

50141

Investigational Site Number 380003, Florence

53226

Investigational Site Number 840064, Wauwatosa

54511

Investigational Site Number 250006, Vandœuvre-lès-Nancy

60453

Investigational Site Number 840005, Oak Lawn

60539

Investigational Site Number 616007, Poznan

60637

Investigational Site Number 840001, Chicago

65265

Investigational Site Number 840024, Mexico

70403

Investigational Site Number 840078, Hammond

71013

Investigational Site Number 380006, San Giovanni Rotondo

77479

Investigational Site Number 840038, Sugar Land

77505

Investigational Site Number 840019, Pasadena

78229

Investigational Site Number 840088, San Antonio

79106

Investigational Site Number 276005, Hamburg

80120

Investigational Site Number 840061, Littleton

85351

Investigational Site Number 840065, Sun City

90302

Investigational Site Number 616002, Lodz

91345

Investigational Site Number 840059, Mission Hills

92114

Investigational Site Number 840074, San Diego

27157-1071

Investigational Site Number 840089, Winston-Salem

98104-2499

Investigational Site Number 840034, Seattle

V6Z 2K5

Investigational Site Number 124002, Vancouver

81-969

Investigational Site Number 616001, Gdynia

90-242

Investigational Site Number 616004, Lodz

90-302

Investigational Site Number 616005, Lodz

63-000

Investigational Site Number 616006, Środa Wielkopolska

03-580

Investigational Site Number 616008, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY